UnitedHealth's Q3 2026 beat leaned on a $610 million reserve release, and the stock gave back a 5% opening gain

UnitedHealth Group reported third-quarter 2026 adjusted earnings of $4.69 a share on Tuesday, October 13, against a $4.14 consensus, and raised its full-year adjusted outlook to at least $20.50 a share, its third increase this year. The stock opened at $397.63, about 5% above Monday's close, sold off through the session and closed at $377.76, down 0.20%.

The fade started within minutes of the release. In thin premarket trading, UNH stood at $389.63 just before the results reached the MoveSurge news feed at 5:55:30 a.m. ET, rose to $395.50 within a minute, a gain of 1.51%, and was back at $389.79, up 0.04%, fifteen minutes later. Our reaction reading at the ten-minute mark, shown in the table below, caught it at $388.00, 0.42% under the starting level.

How much of the beat came from reserves

UnitedHealth's medical care ratio, the share of premiums paid out in medical costs, fell to 88.4% from 89.9% a year earlier. The release says the ratio was helped by $610 million of favorable prior-period reserve development for 2026 dates of service, which is money the company had set aside earlier in the year for claims that turned out to cost less. Mizuho calculated that the ratio beat expectations by about 150 basis points and by about 80 basis points without the reserve benefit, so close to half of the margin beat came from releasing money set aside in earlier quarters rather than from the third quarter's own claims.

The second quarter had leaned on the same source, with $860 million of favorable development, so reserve releases have now supported two consecutive beats.

The ratio usually climbs through the year as members meet their deductibles and the insurer pays a larger share of each claim, which is why it rose from 83.9% in the first quarter. The new floor of $20.50, set against $18.30 of adjusted earnings in the first three quarters, leaves about $2.20 a share for the fourth quarter.

Why the opening gain did not hold

Chief financial officer Wayne DeVeydt said 2027 earnings growth would come in at the low end of the company's 13% to 16% long-term target. Coverage that morning also pointed to enrollment figures that came in slightly below expectations and to the reliance on reserve releases. Revenue of $112.7 billion beat estimates but was below the $113.2 billion of a year earlier, partly because revenue at Optum Health, the care-delivery business, fell 10% as it served fewer patients under value-based contracts.

The selling did not carry into the next session. On Wednesday, October 14, UnitedHealth rose 4.73% to $395.62 while the Nasdaq fell 1.88%, without a new company announcement.